raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:2579

Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome

historical

Synonyms: Furukawa-Takagi-Nakao syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Childhood
Status
historical

A rare hereditary ataxia characterized by neurogenic muscular atrophy associated with signs of cerebellar ataxia, hypesthesia, degeneration of the retina, and diabetes mellitus. Onset of the disease is in adolescence and the course is slowly progressive. There have been no further descriptions in the literature since 1983.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMuscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndromeFurukawa-Takagi-Nakao syndrome
frSyndrome d'atrophie musculaire-ataxie-rétinite pigmentaire-diabèteSyndrome de Furukawa-Takagi-Nakao
deMuskelatrophie-Ataxie-Retinitis pigmentosa-Diabetes mellitus-SyndromFurukawa-Takagi-Nakao-Syndrom
esSíndrome de atrofia muscular-ataxia-retinosis pigmentaria-diabetes mellitus
itSindrome atrofia muscolare-atassia-retinite pigmentosa-diabete mellitoSindrome di Furukawa-Takagi-Nakao
nlMusculaire atrofie - ataxie - retinitis pigmentosa - diabetes mellitusMusculaire atrofie - ataxie - retinitis pigmentosa - diabetes mellitus
ptSíndrome de atrofia muscular-ataxia-retinite pigmentosa-diabetes mellitusSíndrome Furukawa-Takagi-Nakao
plAtrofia mięśni - ataksja - zwyrodnienie barwnikowe siatkówki - cukrzycaZespół Furukawa, Takagi i Nakao
csSyndrom zahrnující svalovou atrofii, ataxii, retinitis pigmentosa a diabetes mellitusFurukawaův-Takagiův-Nakaové syndrom · Furukawa-Takagi-Nakaové syndrom
ukМязова атрофія-атаксія-пігментна дегенерація сітківки-цукровий діабетСиндром Фурукава-Такагі-Накао
zh肌萎缩-共济失调-色素性视网膜炎-糖尿病综合征Furukawa-Takagi-Nakao综合征
trKas atrofisi-ataksi-retinitis pigmentosa-diabetes mellitus sendromuFurukawa-Takagi-Nakao sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM158500Evalidated
ICD-10G11.1NTBTattributedvalidated
MONDO0008023Evalidated
MeSHC538193Evalidated
UMLSC2931765Evalidated
GARD2417Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families12 casesWorldwideCase(s)Validated5748751[PMID]_6302225[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_5748751[PMID]_6302225[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

4 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0007703Abnormality of retinal pigmentation
HP:0001251Ataxia
HP:0003198Myopathy
HP:0005978Type II diabetes mellitus
7

Sources for this card